Table 2.

Grade ≥ 2 adverse events during all treatment cycles regardless of attribution

Toxicity	Grade
	2	3	4
Hematologic adverse events
Anemia	2 (22.2%)	0	0
Leukopenia	1 (11.1%)	2 (22.2%)	0
Lymphopenia	1 (11.1%)	1 (11.1%)	0
Neutropenia	2 (22.2%)	0	2 (22.2%)
Non-hematologic adverse events
Alopecia	4 (44.4%)	0	0
Anxiety	1 (11.1%)	0	0
Depression	1 (11.1%)	0	0
Diarrhea	2 (22.2%)	0	0
Dry mouth	1 (11.1%)	0	0
Dyspnea	0	1 (11.1%)	0
Fatigue	2 (22.2%)	1 (11.1%)	0
Hypertension	0	0	1 (11.1%)
Hypoxia	0	1 (11.1%)	0
Insomnia	1 (11.1%)	0	0
Nausea	1 (11.1%)	0	0
Nervous system disorder-leg cramp	1 (11.1%)	0	0
Oral mucositis	1 (11.1%)	0	0
Tremor	1 (11.1%)	0	0